JPMorgan analyst Jessica Fye downgraded Moderna (NASDAQ: MRNA) from Neutral to Underweight with a price target of $70.00 (from $88.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE